Policy pressure, affordability gaps, and consumer expectations are reshaping how pharma companies think about direct to patient access, according to Deepak Thomas and Sari Kaganoff.
Australia is a prime location for early-phase oncology trials due to its streamlined regulatory process and high-quality infrastructure. Learn how to leverage the CTN scheme and optimize trial design for success.
The ultimate goal of using real-world data (RWD) in clinical research is to ensure a patient is on the right therapy and receiving the right care at the right point in their healthcare journey.
Unlike traditional drugs, AAV therapies require extensive characterization and testing, demanding varying degrees of analysis at each stage of development.
A highly concentrated non-aqueous suspension of an IgG1 was developed using a patented platform. Review how the particle size of the mAb impacts the overall behavior of the drug product.
Learn about a Patient Experience Optimization (PXO) model employing four strategic layers to predict and prevent patient dropout by aligning patient needs with real-time operational support.
Gain seamless, compliant support for your facility lifecycle, from initial validation and qualification to continuous quality operations and expert staff training. A flexible model ensures long-term operational success.
